Dilbro UniCap 110 mcg+50 mcg (Inhalation Capsule)

Unit Price: ৳ 70.00 (3 x 10: ৳ 2,100.00)
Strip Price: ৳ 700.00

Medicine Details

Category Details
Generic Indacaterol glycopyrronium
Company Unimed unihealth pharmaceuticals ltd

Indications

  • Long-term once-daily maintenance bronchodilator treatment
  • Airflow obstruction in COPD patients
  • Not for use in acute bronchospasm
  • Not indicated for asthma

Composition

  • Indacaterol 110 mcg as Indacaterol Maleate INN
  • Glycopyrronium 50 mcg as Glycopyrronium Bromide BP

Pharmacology

  • Inhalation powder drug product
  • Delivery of combination of Glycopyrronium and Indacaterol
  • Beta2-adrenoceptor agonist effects
  • Long-acting muscarinic antagonist effects

Dosage & Administration

  • For oral inhalation only
  • 2 inhalations once daily for maintenance treatment of COPD
  • Recommended dose in elderly patients
  • Not indicated for use in children and adolescents
  • Use at recommended dose in mild to moderate renal impairment
  • Use at recommended dose in mild and moderate hepatic impairment

Interaction

  • No specific interaction studies conducted for combination
  • Concomitant use with β-adrenergic blockers, anticholinergics or sympathomimetic agents not recommended
  • Caution required with concomitant use of hypokalemic treatment

Contraindications

  • Hypersensitivity to Glycopyrronium or Indacaterol
  • Severe hypersensitivity to milk proteins
  • LABA contraindicated in asthma without long-term asthma control medication

Side Effects

  • Cardiovascular effects
  • Ocular disorders
  • Urinary retention
  • Gastrointestinal disorders
  • Dry mouth and cough
  • Immediate hypersensitivity reactions
  • Hypokalemia and hyperglycemia
  • Headache, nervousness, insomnia
  • Muscle spasms, fatigue, malaise and tremor

Pregnancy & Lactation

  • Pregnancy category C
  • Use during pregnancy if benefit justifies potential risk
  • Consideration for breast-feeding women if benefit outweighs possible risk to infant

Precautions & Warnings

  • Increased risk of serious asthma-related events with LABA monotherapy
  • Avoid use in acutely deteriorating COPD or asthma
  • Caution with cardiovascular disorders
  • Use with caution in convulsive disorders, thyrotoxicosis, diabetes mellitus and ketoacidosis
  • Worsening of narrow-angle glaucoma and urinary retention
  • Be alert to hypokalemia and hyperglycemia

Overdose Effects

  • No information on clinically relevant overdosing
  • Potential exaggerated effects of β2-adrenergic stimulants
  • Possible anticholinergic effects
  • Supportive and symptomatic treatment indicated
  • Hospitalization in serious cases

Therapeutic Class

  • Combined bronchodilators

Storage Conditions

  • Avoid direct sunlight or heat
  • Store in cool & dry place
  • Keep away from eyes
  • Keep out of reach of children

Related Brands